Lipoxamycin hemisulfate
CAS No. 11075-87-9
Lipoxamycin hemisulfate( —— )
Catalog No. M21844 CAS No. 11075-87-9
Lipoxamycin has antifungal activity against a panel of humanpathogenic fungi with better potency against some of the Candida species (MIC values, 0.25-16 μg/mL).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 122 | In Stock |
|
| 2MG | 68 | In Stock |
|
| 5MG | 112 | In Stock |
|
| 10MG | 188 | In Stock |
|
| 25MG | 424 | In Stock |
|
| 50MG | 709 | In Stock |
|
| 100MG | 1200 | In Stock |
|
| 200MG | 1609 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLipoxamycin hemisulfate
-
NoteResearch use only, not for human use.
-
Brief DescriptionLipoxamycin has antifungal activity against a panel of humanpathogenic fungi with better potency against some of the Candida species (MIC values, 0.25-16 μg/mL).
-
DescriptionLipoxamycin has antifungal activity against a panel of humanpathogenic fungi with better potency against some of the Candida species (MIC values, 0.25-16 μg/mL). Cryptococcus neoformans is the most sensitive organism, followed by various species of Candida. Other filamentous fungi are sensitive to the Lipoxamycin in disk diffusion assays.Lipoxamycin has a long alkyl chain and an amino-containing polar head group. Lipoxamycin is on the same order of potency as the sphingofungins and also have potent activity against the mammalianenzyme.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetFungal
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number11075-87-9
-
Formula Weight421.54
-
Molecular FormulaC??H??N?O?.?/?H?O?S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 40 mg/mL (94.89 mM; ultrasonic and warming and heat to 60°C)
-
SMILESOC[C@@H](C(N(O)CCC(CCCCCCC(CCCC(C)C)=O)=O)=O)N.OS(O)(=O)=O.[1/2]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. S M Mandala, et al. Inhibition of Serine Palmitoyl-Transferase Activity by Lipoxamycin. J Antibiot (Tokyo). 1994 Mar;47(3):376-9.
2. H A Whaley. The Structure of Lipoxamycin, a Novel Antifungal Antibiotic. J Am Chem Soc. 1971 Jul 28;93(15):3767-9.
molnova catalog
related products
-
Caspofungin acetate
A lipopeptide antifungal agent that works by inhibiting the enzyme 1,3-beta-glucan synthase and thereby disturbing the integrity of the fungal cell wall.
-
Quilseconazole
A novel selective, orally available fungal CYP51 (lanosterol 14-α-demethylase) inhibitor.
-
Itraconazole
A triazole antifungal agent for fungal infections via inhibition of lanosterol 14α-demethylase.
Cart
sales@molnova.com